January 26, 2022 -- Twist Bioscience and Artisan Bio have entered into a collaboration agreement to discover novel antibodies against five undisclosed targets, with an option to expand with additional targets. Under the agreement, Twist will leverage its proprietary library to discover novel antibodies directed against Artisan's immunotherapy targets.
Under the terms of the collaboration between the two companies, Artisan will leverage its immune cell engineering foundry and STAR Guides to develop custom cell therapeutics.
Twist will receive upfront technology access and project fees for each program, success-based clinical, regulatory, and commercial milestones as well as royalties on product sales.
Twist Bioscience is a company focused on offering high-quality synthetic DNA using its silicon platform. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by "writing" DNA on a silicon chip.
Artisan Bio is an immune cell engineering company developing next-generation cell therapies. Artisan Bio's cell engineering and data analysis foundry aims to enable a generation of safer and more efficacious cell therapies.
Copyright © 2022 scienceboard.net